Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1970 2
1971 4
1972 3
1973 2
1974 1
1975 2
1976 1
1977 2
1978 3
1979 4
1980 1
1981 1
1982 2
1983 9
1984 4
1985 2
1986 4
1987 3
1988 2
1989 6
1990 4
1991 4
1992 1
1993 2
1994 3
1995 1
1996 3
1997 8
1998 5
1999 4
2000 4
2001 1
2002 6
2003 5
2004 2
2005 2
2006 5
2007 2
2008 7
2009 6
2010 3
2011 1
2012 9
2013 4
2014 3
2015 1
2016 3
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

157 results
Results by year
Filters applied: . Clear all
Page 1
A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis.
Kappos L, Radue EW, O'Connor P, Polman C, Hohlfeld R, Calabresi P, Selmaj K, Agoropoulou C, Leyk M, Zhang-Auberson L, Burtin P; FREEDOMS Study Group. Kappos L, et al. N Engl J Med. 2010 Feb 4;362(5):387-401. doi: 10.1056/NEJMoa0909494. Epub 2010 Jan 20. N Engl J Med. 2010. PMID: 20089952 Free article. Clinical Trial.
Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial.
Coles AJ, Twyman CL, Arnold DL, Cohen JA, Confavreux C, Fox EJ, Hartung HP, Havrdova E, Selmaj KW, Weiner HL, Miller T, Fisher E, Sandbrink R, Lake SL, Margolin DH, Oyuela P, Panzara MA, Compston DA; CARE-MS II investigators. Coles AJ, et al. Lancet. 2012 Nov 24;380(9856):1829-39. doi: 10.1016/S0140-6736(12)61768-1. Epub 2012 Nov 1. Lancet. 2012. PMID: 23122650 Clinical Trial.
Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial.
Cohen JA, Coles AJ, Arnold DL, Confavreux C, Fox EJ, Hartung HP, Havrdova E, Selmaj KW, Weiner HL, Fisher E, Brinar VV, Giovannoni G, Stojanovic M, Ertik BI, Lake SL, Margolin DH, Panzara MA, Compston DA; CARE-MS I investigators. Cohen JA, et al. Lancet. 2012 Nov 24;380(9856):1819-28. doi: 10.1016/S0140-6736(12)61769-3. Epub 2012 Nov 1. Lancet. 2012. PMID: 23122652 Clinical Trial.
Pegylated interferon β-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study.
Calabresi PA, Kieseier BC, Arnold DL, Balcer LJ, Boyko A, Pelletier J, Liu S, Zhu Y, Seddighzadeh A, Hung S, Deykin A; ADVANCE Study Investigators. Calabresi PA, et al. Lancet Neurol. 2014 Jul;13(7):657-65. doi: 10.1016/S1474-4422(14)70068-7. Epub 2014 Apr 30. Lancet Neurol. 2014. PMID: 24794721 Clinical Trial.
Alemtuzumab improves preexisting disability in active relapsing-remitting MS patients.
Giovannoni G, Cohen JA, Coles AJ, Hartung HP, Havrdova E, Selmaj KW, Margolin DH, Lake SL, Kaup SM, Panzara MA, Compston DA; CARE-MS II Investigators. Giovannoni G, et al. Neurology. 2016 Nov 8;87(19):1985-1992. doi: 10.1212/WNL.0000000000003319. Epub 2016 Oct 12. Neurology. 2016. PMID: 27733571 Free PMC article. Clinical Trial.
Alemtuzumab vs. interferon beta-1a in early multiple sclerosis.
CAMMS223 Trial Investigators, Coles AJ, Compston DA, Selmaj KW, Lake SL, Moran S, Margolin DH, Norris K, Tandon PK. CAMMS223 Trial Investigators, et al. N Engl J Med. 2008 Oct 23;359(17):1786-801. doi: 10.1056/NEJMoa0802670. N Engl J Med. 2008. PMID: 18946064 Free article. Clinical Trial.
[Prion diseases].
Stoĭda NI, Zavalishin IA. Stoĭda NI, et al. Among authors: Zavalishin IA. Zh Nevrol Psikhiatr Im S S Korsakova. 2012;112(9 Pt 2):59-63. Zh Nevrol Psikhiatr Im S S Korsakova. 2012. PMID: 23235426 Review. Russian.
[Spasticity].
Zavalishin IA, Barkhatova VP. Zavalishin IA, et al. Zh Nevrol Psikhiatr Im S S Korsakova. 1997;97(3):68-70. Zh Nevrol Psikhiatr Im S S Korsakova. 1997. PMID: 9157765 Review. Russian. No abstract available.
[MRI-diagnosis of progressive multifocal leukoencephalopathy].
Kulikova SN, Briukhov VV, Peresedova AV, Krotenkova MV, Zavalishin IA. Kulikova SN, et al. Among authors: Zavalishin IA. Zh Nevrol Psikhiatr Im S S Korsakova. 2013;113(10):95-101. Zh Nevrol Psikhiatr Im S S Korsakova. 2013. PMID: 24404655 Review. Russian. No abstract available.
[Compensatory mechanisms in multiple sclerosis(review)].
Peresedova AV, Zavalishin IA. Peresedova AV, et al. Among authors: Zavalishin IA. Zh Nevrol Psikhiatr Im S S Korsakova. 2013;113(2 Pt 2):17-22. Zh Nevrol Psikhiatr Im S S Korsakova. 2013. PMID: 23675603 Review. Russian.
157 results
Jump to page
Feedback